We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Simmons First National
SFNC
$3.45B
| $9.69M | 0.02% |
361,544
+54,507
| +18% | +$1.38M |
|
852
National Fuel Gas
NFG
$7.87B
| $9.68M | 0.02% |
207,948
-17,113
| -8% | -$780K |
|
|
AEL
853
DELISTED
American Equity Investment Life Holding Company
AEL
| $9.65M | 0.02% |
322,290
+18,860
| +6% | +$511K |
|
854
Timken Company
TKR
$9.85B
| $9.64M | 0.02% |
171,283
+6,725
| +4% | +$340K |
|
855
Sarepta Therapeutics
SRPT
$1.68B
| $9.64M | 0.02% |
74,678
+2,675
| +4% | +$270K |
|
856
Quanta Services
PWR
$102B
| $9.63M | 0.02% |
236,621
+21,466
| +10% | +$876K |
|
857
Gaming and Leisure Properties
GLPI
$12.7B
| $9.62M | 0.02% |
223,526
+15,512
| +7% | +$637K |
|
858
FNB Corp
FNB
$6.83B
| $9.62M | 0.02% |
757,114
-25,007
| -3% | -$307K |
|
|
ARI
859
Apollo Commercial Real Estate
ARI
$892M
| $9.59M | 0.02% |
524,517
+39,799
| +8% | +$735K |
|
860
Ameris Bancorp
ABCB
$5.92B
| $9.59M | 0.02% |
225,419
+15,962
| +8% | +$681K |
|
|
HBI
861
DELISTED
Hanesbrands
HBI
| $9.58M | 0.02% |
645,018
+57,783
| +10% | +$878K |
|
862
KB Home
KBH
$3.45B
| $9.56M | 0.02% |
279,072
+10,062
| +4% | +$348K |
|
863
Federated Hermes
FHI
$4.77B
| $9.53M | 0.02% |
292,520
+6,295
| +2% | +$205K |
|
864
Rexford Industrial Realty
REXR
$8.4B
| $9.53M | 0.02% |
208,740
+19,423
| +10% | +$898K |
|
865
Coherent
COHR
$56.4B
| $9.5M | 0.02% |
282,052
-14,706
| -5% | -$469K |
|
866
GATX Corp
GATX
$6.37B
| $9.48M | 0.02% |
114,452
-2,129
| -2% | -$171K |
|
867
LXP Industrial Trust
LXP
$3.56B
| $9.48M | 0.02% |
178,516
+14,738
| +9% | +$789K |
|
868
Nektar Therapeutics
NKTR
$2.38B
| $9.46M | 0.02% |
29,207
+3,414
| +13% | +$990K |
|
869
Avient
AVNT
$3.43B
| $9.39M | 0.02% |
255,321
+6,743
| +3% | +$220K |
|
|
XEC
870
DELISTED
CIMAREX ENERGY CO
XEC
| $9.38M | 0.02% |
178,775
+19,826
| +12% | +$922K |
|
871
United Therapeutics
UTHR
$21.9B
| $9.34M | 0.02% |
106,040
+785
| +0.7% | +$69.1K |
|
872
AMN Healthcare
AMN
$1.28B
| $9.32M | 0.02% |
149,651
+10,460
| +8% | +$619K |
|
873
World Kinect Corp
WKC
$2B
| $9.3M | 0.02% |
214,249
+2,748
| +1% | +$115K |
|
874
Moog Inc Class A
MOG.A
$12.5B
| $9.28M | 0.02% |
108,697
+5,749
| +6% | +$492K |
|
875
Ollie's Bargain Outlet
OLLI
$4.51B
| $9.26M | 0.02% |
141,808
-4,666
| -3% | -$296K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.